Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Cost of Revenue (2018 - 2025)

AVITA Medical filings provide 8 years of Cost of Revenue readings, the most recent being $43.6 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 1814.39% to $43.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.1 million, a 128.2% increase, with the full-year FY2025 number at $53.1 million, up 484.32% from a year prior.
  • Cost of Revenue hit $43.6 million in Q4 2025 for AVITA Medical, up from $3.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $43.6 million in Q4 2025 to a low of $1.1 million in Q3 2021.
  • Median Cost of Revenue over the past 5 years was $3.2 million (2024), compared with a mean of $6.7 million.
  • The widest YoY moves for Cost of Revenue: up 1814.39% in 2025, down 78.72% in 2025.
  • AVITA Medical's Cost of Revenue stood at $1.1 million in 2021, then soared by 482.9% to $6.3 million in 2022, then skyrocketed by 61.08% to $10.2 million in 2023, then plummeted by 77.68% to $2.3 million in 2024, then surged by 1814.39% to $43.6 million in 2025.
  • The last three reported values for Cost of Revenue were $43.6 million (Q4 2025), $3.2 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.